1251 |
Choice and Duration of Antithrombotics After CTO-PCI: Does It Matter? |
Michael S. Lee |
Apr. 12. 21 |
1250 |
Intraplaque vs. Extraplaque Tracking: Association with Procedural Outcomes |
Dimitrios Karmpaliotis |
Apr. 12. 21 |
1249 |
Beyond CTO - Management of the Distal Vessel |
Scott Harding |
Apr. 12. 21 |
1248 |
Management of In-stent Chronic Total Occlusions |
Kevin Croce |
Apr. 12. 21 |
1247 |
Provisional Side Branch Stenting: The Big Misunderstanding |
Thierry Lefevre |
Apr. 12. 21 |
1246 |
Bifurcation PCI Optimization Using Intracoronary Guidance: Optimization Criteria and Supporting Clinical Data |
Myeong-Ki Hong |
Apr. 12. 21 |
1245 |
2021 Clinical Data and Consensus Documents Updates on Bifurcation PCI Techniques: What Are New? |
Adrian P. Banning |
Apr. 12. 21 |
1244 |
Left Main PCI vs. CABG: Form the Final EXCEL Outcomes to Patient Recommendations |
Gregg W. Stone |
Apr. 12. 21 |
1243 |
Indication and Limitation of Antegrade Dissection Reentry |
Shunsuke Matsuno |
Apr. 12. 21 |
1242 |
New Normal of SAPT : Aspirin Drop Era |
Jung Ho Heo |
Apr. 12. 21 |